Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study

Author:

Hsu SimonORCID,Zelnick Leila R.ORCID,Lin Yvonne S.,Best Cora M.ORCID,Kestenbaum Bryan,Thummel Kenneth E.,Rose Lynn M.,Hoofnagle Andrew N.ORCID,de Boer Ian H.ORCID

Abstract

BackgroundConversion of 25-hydroxyvitamin D (25[OH]D) to the active form of vitamin D occurs primarily in the kidney. Observational studies suggest 25(OH)D clearance from the circulation differs by kidney function and race. However, these potential variations have not been tested using gold-standard methods.MethodsWe administered intravenous, deuterated 25(OH)D3 (d-25[OH]D3) in a pharmacokinetic study of 87 adults, including 43 with normal eGFR (≥60 ml/min per 1.73 m2), 24 with nondialysis CKD (eGFR <60 ml/min per 1.73 m2), and 20 with ESKD treated with hemodialysis. We measured concentrations of d-25(OH)D3 and deuterated 24,25-dihydroxyvitamin D3 at 5 minutes and 4 hours after administration, and at 1, 4, 7, 14, 21, 28, 42, and 56 days postadministration. We calculated 25(OH)D clearance using noncompartmental analysis of d-25(OH)D3 concentrations over time. We remeasured 25(OH)D clearance in a subset of 18 participants after extended oral vitamin-D3 supplementation.ResultsThe mean age of the study cohort was 64 years; 41% were female, and 30% were Black. Mean 25(OH)D clearances were 360 ml/d, 313 ml/d, and 263 ml/d in participants with normal eGFR, CKD, and kidney failure, respectively (P=0.02). After adjustment for age, sex, race, and estimated blood volume, lower eGFR was associated with reduced 25(OH)D clearance (β=−17 ml/d per 10 ml/min per 1.73 m2 lower eGFR; 95% CI, −21 to −12). Black race was associated with higher 25(OH)D clearance in participants with normal eGFR, but not in those with CKD or kidney failure (P for interaction=0.05). Clearance of 25(OH)D before versus after vitamin-D3 supplementation did not differ.ConclusionsUsing direct pharmacokinetic measurements, we show that 25(OH)D clearance is reduced in CKD and may differ by race.Clinical Trial registry name and registration numberClearance of 25-hydroxyvitamin D in Chronic Kidney Disease (CLEAR), NCT02937350; Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation (CLEAR-PLUS), NCT03576716

Funder

National Center for Advancing Translational Sciences

Northwest Kidney Centers

National Institute of General Medical Sciences

Karst Waters Institute

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference63 articles.

1. Vitamin D Deficiency

2. Ross AC , Taylor CL , Yaktine AL , Del Valle HB , editors; Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium : Dietary Reference Intakes for Calcium and Vitamin D, Washington, DC, National Academies Press(US), 2011

3. Serum 25-Hydroxyvitamin D Concentrations and Risk for Hip Fractures

4. Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease

5. Vitamin D, Parathyroid Hormone, and Cardiovascular Events Among Older Adults

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3